Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

0 comments

Post a comment

    Post a comment
    Embed Video
    Edit your comment Cancel

    1 Favorite, 1 Group & 1 Event

    Sharing and Open Knowledge and the Future of Scientific Research by Hiroaki Kitano - Presentation Transcript

    1. Sharing and Open Knowledge and the Future of Scientific Research Hiroaki Kitano The Systems Biology Institute Sony Computer Science Laboratories, Inc.
    2.  
    3. EGF Receptor Cascade Oda, et al. Molecular Systems Biology, 2005
    4. Architectural Feature Kitano, Nature Reviews Genetics, Nov. 2004
    5. Copyright ©2007 by the National Academy of Sciences Kim, Pan-Jun et al. (2007) Proc. Natl. Acad. Sci. USA 104, 13638-13642 Fig. 1. Characteristics of essential and nonessential metabolites in E. coli metabolism
    6. Ma et al, Molecular Systems Biology, Sept 2007
    7. Bow-Tie Architecture of Wikipedia links Capocci, et al., Phys Rev. E 74, 036116, 2006
    8. EGF Receptor Cascade Oda, et al. Molecular Systems Biology, 2005
    9. Oda, et al. Molecular Systems Biology, 2005
    10.  
    11. TLR Bow-Tie Structure Oda and Kitano, Molecular Systems Biology, April 2006
    12. 低下する製薬産業の生産性
    13. Copyright ©2003 by the National Academy of Sciences Borisy, Alexis A. et al. (2003) Proc. Natl. Acad. Sci. USA 100, 7977-7982 Multicomponent therapeutics that prevent proliferation of fluconazole-resistant C. albicans CombinatoRX (CRXX: NASDAQ) cHTS
    14. Copyright ©2003 by the National Academy of Sciences Borisy, Alexis A. et al. (2003) Proc. Natl. Acad. Sci. USA 100, 7977-7982 Chlorpromazine , an antipsychotic agent, and pentamidine , an antiprotozoal agent, together selectively prevent tumor cell growth in vitro and in vivo Phase 1/2A Stage
    15. Copyright ©2003 by the National Academy of Sciences Borisy, Alexis A. et al. (2003) Proc. Natl. Acad. Sci. USA 100, 7977-7982 Chlorpromazine , an antipsychotic agent, and pentamidine , an antiprotozoal agent, together selectively prevent tumor cell growth in vitro and in vivo Phase 1/2A Stage Efficacy
    16.  
    17. 朝鮮人参の成分分析 Wang, M. et al., Phytother Res. 2005 Mar;19(3):173-82
    18. Open Pharma
      • Combination of Generic compounds to generate highly effective drugs
      • Equivalent efficacy by partial replacement of compounds
      • Value lies in “Combination” rather than compound itself.
      • Toward open source pharmaceutical industry
      The Rule of the Game Will Change
    19. “ PAYAO” Web 2.0 Community Tagging System to SBML models Okinawa Institute of Science and Technology The Systems Biology Institute
    20. “PAYAO”
      • an artificial floating raft where fish congregate
    21. Payao: Web2.0 Community-Based Biological Knowledge Accumulation System
    22. SBML Models Tagging System Manage Models, Users, Groups Register a model Store models, Tags, Comments Login Users Visitors Model Owner Add Comments Add/Edit Tags to the model View Models with CellDesigner notation Group A Group B *CellDesigner files PAYAO SBML Models Tagging System SBML files
    23. Model View
    24. Model View with Tag Marks
    25. Tag
    26. View a Tag
    27. Add Comments to a Tag
    28. View Comments to a Tag
    29. PubMed ID Link
    30. Healthcare & Wellness Concierge Genome Diagnosis (23 and me) Wellness (India, etc) Personalized & Preventive medicine How to integrate medicine and wellness? Herbal medicine, meditation, etc. Novel Drug Design and Integrated Healthcare Support
    31. Summary
      • Networks are complex but has sort of “design principles”
      • Long tail drug need to be pursued to create more effective drugs
      • Open Pharma may open up a whole new paradigm of drug design, distribution, and services.
      • Open infrastructure is the key for success

    + iCommons iSummitiCommons iSummit, 2 years ago

    custom

    1447 views, 1 favs, 0 embeds more stats

    More info about this document

    CC Attribution-ShareAlike LicenseCC Attribution-ShareAlike License

    Go to text version

    • Total Views 1447
      • 1447 on SlideShare
      • 0 from embeds
    • Comments 0
    • Favorites 1
    • Downloads 3
    Most viewed embeds

    more

    All embeds

    less

    Flagged as inappropriate Flag as inappropriate
    Flag as inappropriate

    Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

    Cancel
    File a copyright complaint
    Having problems? Go to our helpdesk?

    Categories